215 related articles for article (PubMed ID: 19016076)
1. Early effects of sodium valproate monotherapy on serum paraoxonase/arylesterase activities.
Karikas GA; Schulpis KH; Bartzeliotou A; Regoutas S; Thanopoulou C; Papaevangelou V; Giannoulia-Karantana A; Papassotiriou I; Fytou-Pallikari A
Scand J Clin Lab Invest; 2009; 69(1):31-5. PubMed ID: 19016076
[TBL] [Abstract][Full Text] [Related]
2. The effect of diet on Paraoxonase 1/Arylesterase activities in patients with disorders of galactose metabolism.
Schulpis KH; Karikas GA; Bartzeliotou A; Papakonstantinou ED; Kalogerakou M; Tsakiris S
Clin Endocrinol (Oxf); 2007 Nov; 67(5):687-92. PubMed ID: 17593248
[TBL] [Abstract][Full Text] [Related]
3. Alpha-tocopherol supplementation prevents the exercise-induced reduction of serum paraoxonase 1/arylesterase activities in healthy individuals.
Tsakiris S; Karikas GA; Parthimos T; Tsakiris T; Bakogiannis C; Schulpis KH
Eur J Clin Nutr; 2009 Feb; 63(2):215-21. PubMed ID: 17882129
[TBL] [Abstract][Full Text] [Related]
4. Oxidative status and serum PON1 activity in beta-thalassemia minor.
Selek S; Aslan M; Horoz M; Gur M; Erel O
Clin Biochem; 2007 Mar; 40(5-6):287-91. PubMed ID: 17296173
[TBL] [Abstract][Full Text] [Related]
5. Valproic acid monotherapy induces DNA oxidative damage.
Schulpis KH; Lazaropoulou C; Regoutas S; Karikas GA; Margeli A; Tsakiris S; Papassotiriou I
Toxicology; 2006 Jan; 217(2-3):228-32. PubMed ID: 16289809
[TBL] [Abstract][Full Text] [Related]
6. Serum lipid profile paraoxonase and arylesterase activities in psoriasis.
Toker A; Kadi M; Yildirim AK; Aksoy H; Akçay F
Cell Biochem Funct; 2009 Apr; 27(3):176-80. PubMed ID: 19330810
[TBL] [Abstract][Full Text] [Related]
7. Serum paraoxonase/arylesterase activities in phenylketonuric patients on diet.
Schulpis KH; Bartzeliotou A; Tsakiris S; Gounaris A; Papassotiriou I
Eur J Clin Nutr; 2007 Jun; 61(6):803-8. PubMed ID: 17203019
[TBL] [Abstract][Full Text] [Related]
8. Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population.
Elkiran ET; Mar N; Aygen B; Gursu F; Karaoglu A; Koca S
BMC Cancer; 2007 Mar; 7():48. PubMed ID: 17362500
[TBL] [Abstract][Full Text] [Related]
9. Paraoxonase and arylesterase activity and total oxidative/anti-oxidative status in patients with chronic adenotonsillitis.
Koc S; Aksoy N; Bilinc H; Duygu F; Uysal IÖ; Ekinci A
Int J Pediatr Otorhinolaryngol; 2011 Nov; 75(11):1364-7. PubMed ID: 21893350
[TBL] [Abstract][Full Text] [Related]
10. Maternal chronic hepatitis B virus is implicated with low neonatal paraoxonase/arylesterase activities.
Schulpis KH; Barzeliotou A; Papadakis M; Rodolakis A; Antsaklis A; Papassotiriou I; Vlachos GD
Clin Biochem; 2008 Mar; 41(4-5):282-7. PubMed ID: 18035058
[TBL] [Abstract][Full Text] [Related]
11. Effects of valproate, carbamazepine, and levetiracetam on the antioxidant and oxidant systems in epileptic patients and their clinical importance.
Varoglu AO; Yildirim A; Aygul R; Gundogdu OL; Sahin YN
Clin Neuropharmacol; 2010 May; 33(3):155-7. PubMed ID: 20502135
[TBL] [Abstract][Full Text] [Related]
12. Effect of preoperative atorvastatin therapy on paraoxonase activity and oxidative stress after coronary artery bypass grafting.
Kurban S; Mehmetoglu I; Ege E
Perfusion; 2009 Jul; 24(4):271-6. PubMed ID: 19843623
[TBL] [Abstract][Full Text] [Related]
13. Levels of paraoxonase and arylesterase activities and malondialdehyde in workers exposed to ionizing radiation.
Serhatlioglu S; Gursu MF; Gulcu F; Canatan H; Godekmerdan A
Cell Biochem Funct; 2003 Dec; 21(4):371-5. PubMed ID: 14624476
[TBL] [Abstract][Full Text] [Related]
14. Paraoxonase and arylesterase activities in coronary artery disease.
Gur M; Aslan M; Yildiz A; Demirbag R; Yilmaz R; Selek S; Erel O; Ozdogru I
Eur J Clin Invest; 2006 Nov; 36(11):779-87. PubMed ID: 17032345
[TBL] [Abstract][Full Text] [Related]
15. Paraoxonase and arylesterase activities in untreated dipper and non-dipper hypertensive patients.
Yildiz A; Gur M; Demirbag R; Yilmaz R; Akyol S; Aslan M; Erel O
Clin Biochem; 2008 Jul; 41(10-11):779-84. PubMed ID: 18355454
[TBL] [Abstract][Full Text] [Related]
16. Oxidant and antioxidant of arylesterase and paraoxonase as biomarkers in patients with hepatitis C virus.
Ali EM; Shehata HH; Ali-Labib R; Esmail Zahra LM
Clin Biochem; 2009 Sep; 42(13-14):1394-400. PubMed ID: 19538950
[TBL] [Abstract][Full Text] [Related]
17. PON1 activity and total oxidant status in patients with active pulmonary tuberculosis.
Selek S; Cosar N; Kocyigit A; Erel O; Aksoy N; Gencer M; Gunak F; Aslan M
Clin Biochem; 2008 Feb; 41(3):140-4. PubMed ID: 18154731
[TBL] [Abstract][Full Text] [Related]
18. Gender related differences in paraoxonase 1 response to high-fat diet-induced oxidative stress.
Thomàs-Moyà E; Gómez-Pérez Y; Fiol M; Gianotti M; Lladó I; Proenza AM
Obesity (Silver Spring); 2008 Oct; 16(10):2232-8. PubMed ID: 18719679
[TBL] [Abstract][Full Text] [Related]
19. High levels of homocysteine and low serum paraoxonase 1 arylesterase activity in children with autism.
Paşca SP; Nemeş B; Vlase L; Gagyi CE; Dronca E; Miu AC; Dronca M
Life Sci; 2006 Apr; 78(19):2244-8. PubMed ID: 16297937
[TBL] [Abstract][Full Text] [Related]
20. Serum paraoxonase and arylesterase activity and oxidative status in patients with multiple sclerosis.
Kirbas A; Kirbas S; Anlar O; Efe H; Yilmaz A
J Clin Neurosci; 2013 Aug; 20(8):1106-9. PubMed ID: 23669169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
